Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Revue Du Rhumatisme (Ed. Francaise : 1993)|December 1, 1993
[Tissue and systemic diffusion of idrocilamide after cutaneous administration]B Bannwarth, J C Le Huec, G Vinçon, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Cystic fibrosis: production of high levels of uromodulin-like protein by HLA-DR blood monocytes differentiating towards a fibroblastic phenotypeM L Labat, A F Bringuier, C Seebold-Choqueux, et al.
Atherosclerosis|April 5, 1996
Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesionsC Duplàa, T Couffinhal, L Labat, et al.
Anesthesiology|May 17, 2019
Dextromethorphan Analgesia in a Human Experimental Model of HyperalgesiaE Martin, C Narjoz, X Decleves, et al.
Bone and Mineral|December 1, 1993
Immune cell defects affect bone remodelling in osteopetrotic op/op miceC Philippart, E Tzehoval, Y Moricard, et al.
Cancer Detection and Prevention|January 1, 1996
Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemiasI Blazsek, C Farabos, P Quittet, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Excess of lympho-reticular cell complexes in the bone marrow linked to T cell mediated dysmyelopoiesisI Blazsek, E Goldschmidt, D Machover, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Possible monocytic origin of chondrosarcoma: in vitro transdifferentiation of HLA-DR blood monocyte-like cells from a patient with chondrosarcoma, into neo-fibroblasts and chondrocyte-like cellsM L Labat, A F Bringuier, C Séébold-Choqueux, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemiaI Blazsek, C Farabos, M Musset, et al.
Cancer Detection and Prevention|January 1, 1992
Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisoneI Blazsek, M Musset, D Boulé, et al.
Pageof 7